Related Experiment Video

Updated: Apr 15, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

10.4K

Towards protein-based viral mimetics for cancer therapies

Ugutz Unzueta1, María Virtudes Céspedes2, Esther Vázquez1

  • 1Institut de Biotecnologia i de Biomedicina, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain; Departament de Genètica i de Microbiologia, Universitat Autònoma de Barcelona, Bellaterra, 08193 Barcelona, Spain; CIBER de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN), Bellaterra, 08193 Barcelona, Spain.

Trends in Biotechnology
|March 26, 2015
PubMed

Insights

Artificial viruses, or virus-mimetic nanocarriers, offer a novel approach to cancer therapy. Protein-based nanocarriers show promise for enhanced drug delivery, improving tumor targeting and reducing toxicity.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Oncology

Background:

  • Cancer therapies often require maximum drug doses due to resistance and recurrence, leading to severe toxicities.
  • Efficient drug accumulation in tumor tissues is crucial for improving therapeutic outcomes and minimizing side effects.

Purpose of the Study:

  • To introduce a new class of therapeutic drugs based on virus-mimetic nanocarriers, termed 'artificial viruses'.
  • To highlight the potential of protein-based nanocarriers for enhanced antitumor drug delivery.

Main Methods:

  • Exploration of protein-based materials for designing virus-like molecular vehicles.
  • Development of nanocarriers with 'smart' functions and biomimetic traits.

Main Results:

  • Protein-based nanocarriers offer superior structural and functional versatility compared to conventional drug conjugates.
  • These nanocarriers are designed for efficient delivery of antitumor drugs to tumor tissues.

Conclusions:

  • Protein-based nanocarriers represent a promising advancement over current drug-protein conjugates.
  • Artificial viruses have the potential to significantly improve cancer treatment efficacy and patient safety.
Keywords:
biomaterialsbiomimeticsdrug deliveryprotein engineeringprotein nanoparticlestargeted therapy

More Related Videos

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting11:58

Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting

Published on: March 8, 2018

8.1K
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.6K

Related Concept Videos

Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
36
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.3K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.2K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.5K